Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R33 NS096044
NIGMS NIH HHS
Grant: T32 GM008243
NINDS NIH HHS
Grant: R01 NS088766
NICHD NIH HHS
Grant: P50 HD103525
National Institutes of Health
Grant: 3R21NS096044-01S1
Modified neural stem cells for slycosylation-independent treatment of MPS IIIB
National Institutes of Health
Grant: 5R01NS088766-06
Phenotypic Effects of Brain-Directed Enzyme Therapy for Sanfilippo B Syndrome
National Institutes of Health
Grant: 4R33NS096044-03
Modified neural stem cells for glycosylation-independent treatment of MPS IIIB
National Institutes of Health
Grant: 1R41NS092221-01A1
Engineering stem cells to make mucopolysaccharidosis IIIB
National Institutes of Health
Grant: 5T32GM008243-07
MEDICAL GENETICS - UCLA INTERCAMPUS PROGRAM
NIH
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals